Secondary Metabolite Production in Plant Cell Culture: Bioreactors and Scale-Up

Level: BS Botany (BOT-608, Plant Tissue Culture) and advanced school biology. This lesson builds on the tissue culture laboratory lesson, the cell suspension culture lesson and the somaclonal variation lesson — read those first if callus, liquid culture and cell-line drift are new to you.
Many of the most valuable chemicals in medicine and cosmetics are made by plants: the anticancer drug paclitaxel (a complex molecule first found in yew bark), the red pigment shikonin, the yellow antimicrobial alkaloid berberine. Harvesting them from plants is slow, wasteful and sometimes impossible — a yew tree grows for decades and yields grams. This lesson is about the alternative: growing the plant's own cells in tanks, persuading them to make the chemical, and scaling that persuasion from a shaking flask to a vessel of 75,000 litres. It explains what secondary metabolites are, which culture systems make them, how producers raise the yield (selection, two-stage media, elicitors, feeding, trapping, immobilisation), why hairy roots often beat loose cells, how bioreactors are chosen for cells that tear easily, and why — after fifty years of work — only a short list of products has ever paid its way.
What are secondary metabolites? The plant's defence and display chemicals
A plant cell runs two kinds of chemistry. Primary metabolites (the compounds every living cell needs for basic growth and division — sugars, amino acids, nucleotides, lipids and the proteins built from them) keep the cell alive. Secondary metabolites (compounds the plant makes for its life in the world rather than for basic growth — poisons, pigments, scents, bitter tastes and signals) do the jobs outside the cell: they deter grazing animals, poison fungi, attract pollinators, shade the leaf from ultraviolet light and bargain with soil microbes. A cell can live and divide in a flask with its secondary pathways switched off; the whole plant in a field often cannot survive without them.
Three properties shape everything in this lesson. First, secondary metabolites are restricted: each family of compounds is usually made by a small group of related plants — paclitaxel by yews, shikonin by one genus of the borage family, morphine by one poppy species — so there is no common factory organism to borrow, as there is with bacteria and insulin. Second, they are often complex: paclitaxel's structure took chemists decades to copy in a flask, and copying it is still too expensive for supply, which is exactly why the living cell keeps its job. Third, they are often scarce in the plant: a valuable compound may be a fraction of a percent of the bark or root that holds it, locked inside a slow-growing or rare plant. Scarcity plus complexity plus medical value is the business case for everything that follows.
The pathways themselves are branches off primary metabolism. An alkaloid (a nitrogen-containing, usually bitter and often pharmacologically active secondary compound — berberine, morphine and the tropane alkaloids are examples) is built from amino acids. A terpenoid (a compound built from five-carbon isoprene units — paclitaxel and the ginsenosides' parent skeletons are examples) is built from acetyl-CoA (the cell's central two-carbon carrier). A phenolic (a compound carrying an aromatic ring with a hydroxyl group — rosmarinic acid is an example) is built largely from the amino acid phenylalanine. Knowing the family tells the producer which building blocks to feed and which signals might switch the pathway on, two tools this lesson returns to.
Why grow cells instead of plants? When a tank beats a field
The case for culture rests on the failures of the field. Slow plants: ginseng roots are harvested after four to six years, and a Pacific yew needs decades to reach bark-harvesting size. Rare plants: wild populations of several drug plants have been stripped by collectors, and some are legally protected. Unreliable plants: field content swings with season, soil, weather and variety, while a drug maker must deliver the same molecule every batch. Expensive plants: some source plants grow only in one valley or one climate. A tank of cells answers all four: it grows all year, in any country, under fixed conditions, from a line whose output is measured — provided the cells can be made to produce, which is the hard part this lesson spends most of its length on.
The case against culture is cost, and it must be stated plainly at the start. A field of plants runs on sunlight and rain; a cell factory runs on sterile steel, purified water, sugars, electricity and skilled labour, and plant cells grow slowly, so every litre of vessel earns its money slowly. Culture wins only where the product is valuable enough and the plant supply bad enough — the arithmetic is done openly in the limits section at the end. The techniques below exist to push that arithmetic in the producer's favour.
The production systems: callus, suspensions and organised cultures
Four culture forms do the producing. Callus (a soft mass of unspecialised dividing cells, raised on solid or semi-solid medium) is the easiest to start and the first form screened, but it grows slowly and is hard to scale. A cell suspension culture (callus broken up and grown as small clumps and single cells dispersed in liquid medium, kept moving by shaking or stirring) is the production workhorse: it can be piped, sampled and poured into vessels, and the cell suspension lesson covers its making in full. Organised cultures — shoot cultures and, above all, hairy roots — keep the plant's own tissue plan, and with it the pathways that belong to that tissue. Immobilised cells, described in their own section below, are suspension cells held in a gel or foam so the medium can flow past them.

Now the disappointment that organises the whole subject. A student reasonably expects that cells taken from a drug plant will make the drug. Very often they make almost none. The reason is developmental: in the whole plant the pathway runs in specialised cells or structures — a bark layer, a root, a gland — with its enzymes switched on by that tissue's signals and its product stored in that tissue's compartments. A lump of undifferentiated callus has neither the signals nor the compartments. The pathway genes are present in every cell (the totipotency principle: the full genome rides in every living cell), but presence is not expression. Any claim that a culture will automatically match the whole plant is false, and believing it is the beginner's classic error. Production is earned, by the five levers of the next three sections: select a rare high-producing line, stage the culture so growth and production get different conditions, elicit the defence pathways, feed the pathway's building blocks and trap the product before it can switch its own making off.
Lever one: select a high-producing cell line
A callus or suspension is not one genotype repeated; it is a population of cells that differ, and the differences include how much product each cell's descendants make. The variation is the same somaclonal restlessness described in the somaclonal variation lesson — there it was a nuisance for cloners; here it is raw material. Cell line selection (repeatedly assaying many small cultures, keeping the highest producers and discarding the rest, cycle after cycle) exploits it.
WHAT is done: the population is divided into many small lines — small callus pieces, or single cells and small clumps grown into colonies — and each line is chemically assayed (measured for the product it holds). WHY: production is a property of individual cell lineages, and the average of a mixed population hides the rare excellent ones. HOW: keep the top few percent, grow them up, divide again, assay again. Coloured products make the first screen easy — shikonin lines can be picked by eye, the deepest red pieces kept — while colourless products need chemical screening of every line.
Two results show what selection can reach. Working with Coptis japonica (a Japanese medicinal plant of the buttercup family), Sato and Yamada selected cell lines for the yellow alkaloid berberine until the best lines held several percent of their dry weight as berberine — figures up to roughly 13% were reported — far above the level in the plant's roots. With Coleus blumei (now Plectranthus scutellarioides, a mint-family ornamental), selected suspension lines accumulated the phenolic rosmarinic acid up to about 15% of dry weight in the best reported work, rivalling the leaf itself. Selection does not create these pathways; it finds and concentrates the cells that run them hardest.
Worked example (clearly labelled practice numbers). A project divides a new culture into 400 candidate lines. Experience says about 5% of lines will be high producers worth keeping. Expected keepers = 400 × 5⁄100 = 20 lines. Those 20 go forward to stability testing; the other 380 are discarded. The arithmetic is the planning tool: if a project needs twenty good lines and the hit rate is 5%, it must screen four hundred — there is no smaller honest version of the experiment.
Selection has a shelf life. A high-producing line kept in continuous subculture tends to drift: faster-growing, lower-producing cells outgrow the rest, and yield slides over months. The industrial answer is cell banking (preserving a verified stock of the line — commonly frozen by the methods of the cryopreservation work in this course — and starting every production campaign from that master stock). When a working culture's yield fades, the sound response is not to dose it with more hormone but to go back to the bank and restart from the preserved line.
Lever two: two-stage culture — grow first, produce second
The deepest single idea in this lesson is that growth and production want different conditions, and a good process gives them different media in sequence. A young culture dividing at full speed spends its carbon and energy on new cells. The defence chemistry that makes most secondary metabolites is largely switched off during that rush, and many products accumulate only when division slows. A two-stage culture (a process run in two media one after the other: a growth medium that maximises cell mass, then a production medium that maximises product) matches the process to that biology.
The founding example is shikonin. Shikonin (a deep red naphthoquinone pigment — naphthoquinones are a family of coloured, biologically active ring compounds — from the roots of Lithospermum erythrorhizon, a borage-family plant used in East Asian medicine) was wanted for cosmetics and ointments, but the plant is slow: about three years of growth stand behind every root harvest. At Mitsui Petrochemical Industries in Japan, Yasuhiro Fujita's team cultured the cells instead. They found the cells would grow well in a standard growth medium but made little pigment in it. Fujita and colleagues therefore designed a second medium purely for production — the M-9 medium, published in 1981 — and ran the process in two stages: multiply the cells in growth medium, then transfer them to M-9, where they accumulated shikonin derivatives to around 10% of their dry weight, several times the root's level. In 1984 Mitsui brought the cultured-cell pigment to market — the first commercial product of plant cell culture anywhere, sold for cosmetics such as lipstick.
WHAT a production medium changes, and WHY each change works. Nutrient limits: phosphate or nitrate are cut, because shortage is a stress signal — a cell that cannot divide spends on defence instead, and many pathways answer to exactly that signal. Sugar level: sucrose is often raised, because a non-dividing culture still needs carbon to build product with. Growth regulators: the auxin balance is shifted or auxin removed, because the hormone settings that drive division (the subject of the growth regulators lesson and the cytokinins lesson) commonly suppress production pathways. Timing: the switch is thrown when the culture is dense and healthy — eliciting or starving a thin young culture produces a little product from few cells, while the same switch thrown by a full culture produces it in quantity. Sequence is the whole trick: biomass first, product second.
Lever three: elicitors — switching the pathway on with a fake attack
Most valuable metabolites are weapons. The plant makes them when it believes it is attacked — and the producer's third lever is to fake the attack. An elicitor (any substance or treatment that switches on a plant's defence responses) is added to the production-stage culture, and the defence pathways answer by making their chemicals.
Biotic elicitors (elicitors that come from living attackers or their parts) include preparations of fungal cell walls, yeast extract, and chitosan (a compound made from chitin, the material of fungal walls and crustacean shells; plant cells read its fragments as "fungus present"). Signalling elicitors are the plant's own alarm molecules, added directly: methyl jasmonate (the volatile form of jasmonic acid, the wound-and-attack hormone at the centre of plant defence signalling) and salicylic acid (the signal behind systemic disease resistance). Abiotic elicitors (elicitors that are not from living things) include ultraviolet light, heavy-metal salts and osmotic stress. The chain is the same in each case: the cell detects the signal, defence genes switch on, pathway enzymes are made, and product rises — usually over days, and usually best in a culture that has finished growing, which is why elicitation belongs to stage two.
The best-documented case is paclitaxel. Paclitaxel (trade name Taxol; a diterpenoid — a terpenoid built from twenty carbons — that blocks cell division and is used against several cancers) is part of the yew's chemical defence, and in Taxus cell cultures a dose of methyl jasmonate after the growth phase raises paclitaxel production strongly. Elicitor dose and timing are tuned like any other variable: too little and the pathway barely stirs; too much and the cells are damaged and production falls with their health. Elicitation is a negotiation with a defence system, not a switch that can be forced.
Levers four and five: feed the pathway, trap the product
Precursor feeding (supplying the culture with a building block from part-way along the product's pathway, so the cells finish the job instead of making the block themselves) attacks bottlenecks. If the early steps of a pathway run slowly, a later intermediate fed into the medium can lift output sharply: phenylalanine feeding is the standard example for phenolic products such as rosmarinic acid, because phenylalanine is the pathway's front door. Feeding works only when the downstream enzymes are present and waiting — one more reason it is paired with line selection and elicitation rather than used alone. Medium design as a whole — which salts, which sugar, which regulators — is treated in the media components lesson.
In-situ product removal (trapping the product in a second phase inside the same vessel, as fast as the cells release it) attacks a quieter problem. Many metabolites are excreted (released out of the cell) into the medium, where three bad things can happen: the product switches its own pathway off (feedback inhibition — the end product of a pathway slowing the pathway's own early enzymes), enzymes or chemistry in the medium break it down, or it poisons the producing cells. A second phase — an adsorbent resin (a solid sponge-like material, such as the XAD resins, that soaks up organic molecules), or an inert oil or paraffin layer floating on the broth — captures the product as it appears. The cells, relieved of the feedback signal, keep producing; at harvest, the trap is collected instead of thousands of litres of broth. The classic shikonin process used a paraffin layer for exactly this purpose.
Immobilised cells (living cells trapped inside a gel bead or foam matrix, held in place while medium flows past them) combine several advantages. The standard matrix is calcium alginate (a seaweed-derived jelly that sets gently when dripped into a calcium solution — gentle enough that cells survive being trapped), formed as small beads with the cells inside; polyurethane foam blocks are the other common support, and shikonin-producing Lithospermum cells immobilised in polyurethane foam are the textbook demonstration. Immobilised cells grow slowly — usually a help, since production and growth compete — the medium can be exchanged without losing the biomass, a production phase can be run again and again on the same cells, and secreted product is collected from the outflowing medium. The price is engineering: oxygen and nutrients must reach the bead centres, and a system that works in a jam jar is not trivial to build at scale.
Hairy roots: the organised alternative
Where a pathway belongs to roots, the surest way to keep it running is to culture roots. Hairy root disease in nature is caused by the soil bacterium Agrobacterium rhizogenes (also classified as Rhizobium rhizogenes). The bacterium carries a large Ri plasmid (root-inducing plasmid: a ring of bacterial DNA separate from the bacterium's chromosome); on infecting a wounded plant it transfers a segment of that plasmid, the T-DNA (transferred DNA), into the plant's own genome. The T-DNA carries rol genes (root-locus genes whose expression reprogrammes the infected cells), and the reprogrammed cells pour out masses of fine, highly branched roots — the hairy roots. A laboratory does deliberately what the bacterium does in soil: infect explants, cut away the emerging roots, and clean them of bacteria. The result is a hairy root culture: a clone of transformed root tissue that keeps the T-DNA in every cell. The method sits inside the wider family of root culture work covered in the root and hairy root cultures lesson.

Hairy roots earn their place on four properties. Speed: they grow fast, branching constantly, on medium with no added growth regulators — the rol genes supply the growth programme. Fidelity: they are organised root tissue, so root pathways stay switched on: tropane alkaloids in Hyoscyamus and Atropa root cultures, ginsenosides (the saponin compounds behind ginseng's reputation) in Panax root cultures, at levels that can approach the field root. Stability: their genome stays steady over long periods, without the drift that eats suspension lines — organised tissue disciplines its cells, the same reason organised routes such as somatic embryogenesis and organogenesis behave more predictably than naked protoplast systems. Harvest logic: many root products are stored inside the root tissue, so the biomass itself is the product package.
The weakness is physical, and it is severe. A growing root culture becomes a dense, tangled mat. Liquid cannot flow evenly through it, oxygen cannot reach its centre, and new medium cannot be exchanged uniformly — the inside of a large root mass starves while the outside thrives. Engineers answer with reactors built for roots: mist reactors (the roots hang in air and nutrient medium is sprayed over them as a fine mist) and trickle-bed reactors (medium rains over a supported root mass and is recirculated). These work, but they cap the practical size of a hairy-root process far below the stirred-tank giants — the standing trade of this whole lesson: organised cultures produce better and scale worse.
Why plant cells are difficult passengers in a tank
Industrial microbiology stirs bacteria and yeasts hard, because they can take it. Plant cells cannot, and the reasons are written in their anatomy. Size: a plant cell is commonly tens of micrometres across — tens of times wider than a bacterium — so turbulence that a microbe never notices catches a plant cell like a sail. The vacuole: most of that size is one water-filled central vacuole pressed against a thin skin of cytoplasm and wall, a structure that ruptures under shear stress (the tearing force produced when layers of liquid move at different speeds, strongest near impeller tips and in bursting bubbles). Aggregates: plant cells stick together in clumps of a few to hundreds of cells, so the unit being stirred is larger still, and the cells inside a clump see different conditions from those outside. Speed: plant cells divide slowly — doubling times of roughly one to several days against an hour or so for a bacterium — so a batch runs for weeks, and every one of those weeks must stay sterile (the aseptic discipline of the basic concepts lesson, held for a month inside a steel vessel instead of for an afternoon at a bench). Oxygen: their demand is modest, which is merciful, because gentle mixing delivers modest oxygen transfer — the design must still guarantee that no corner of a large vessel suffocates quietly.
When a stirred run fails with ruptured cells and poor growth, the diagnosis follows directly: the cells were torn, not starved. The correct first response is mechanical — a slower or larger impeller, a different impeller shape, or a move to air-driven mixing. Feeding a shear-damaged culture more sugar repairs nothing. Naming the cause correctly is most of bioreactor engineering.
Bioreactors: four ways to mix without tearing
A bioreactor (a closed, sterilisable vessel in which cultured cells are grown under controlled aeration, mixing, temperature and acidity) for plant cells must solve one equation: mix and aerate a large volume while keeping shear low. Four designs dominate, and they trade the terms of that equation differently.
| Reactor | How it mixes | Strength for plant cells | Weakness |
|---|---|---|---|
| Stirred tank | A motor-driven impeller on a central shaft | The strongest, most controllable mixing and oxygen transfer; the design behind the largest successful processes | The impeller is the main shear source; seals and shafts complicate sterility |
| Bubble column | Air sparged (bubbled) in at the base of a tall column; bubbles mix as they rise | Simplest and gentlest of the steel-and-glass designs; no moving parts in the broth | At large scale, bubble mixing alone leaves uneven zones — some regions starved, others over-aerated |
| Airlift | Bubbles rise inside a draught tube (an open inner cylinder); broth circulates up inside it and down outside | Guided, gentle circulation with good oxygen delivery and no impeller — a favourite for suspensions | Circulation weakens in very thick, dense cultures; design is less flexible than a stirred tank |
| Wave (rocking) reactor | A disposable plastic bag of culture is rocked on a platform; waves in the liquid mix and aerate it | Very low shear; the bag arrives sterile and is thrown away — no cleaning or steam sterilisation | Bag sizes cap the working volume; not the tool for the very largest runs |

From flask to factory in five steps
Use the buttons to walk through one production run. Reset returns to the starting caption.
Follow a production run from one screened cell line to a harvested tank — the five steps every plant-cell factory repeats.
Scale-up, step by step: the seed train
No process jumps from a 250-millilitre flask to a 75,000-litre vessel in one move. Scale-up (the staged enlargement of a process from laboratory to production volume) runs through a seed train (the chain of ever-larger cultures — flask, small reactor, pilot vessel, production vessel — each grown up to inoculate, that is seed, the next). WHAT grows at each step is cell mass; WHY the steps exist is that the final vessel must start filled with vigorous, verified cells, not with a flask's worth diluted in an ocean; HOW the engineer keeps faith with the laboratory result is by holding the conditions that matter — oxygen transfer, mixing time, shear — as steady as the geometry allows while the volume climbs roughly tenfold per step. Each transfer is also an inspection point: a seed stage that looks wrong is discarded for the price of a flask, not a factory.

The paclitaxel process shows where the staircase can lead. The company Phyton Biotech, in Germany, runs plant cell fermentation (its trade name for large-scale plant cell culture) of Taxus cells in stirred production vessels of 45,000 and 75,000 litres — over 200,000 litres of installed capacity, among the largest plant-cell processes ever operated. The drug maker Bristol-Myers Squibb licensed the process in 1995, because fermentation freed paclitaxel supply from yew bark. Compare the sister technology of the micropropagation stages: micropropagation scales up plants, stage by stage; metabolite production scales up chemistry, vessel by vessel. The seed train is where the two ideas meet — a multiplication staircase, climbed by cells instead of shoots.
Worked example (clearly labelled practice numbers at the real vessel scale). Suppose a Taxus culture in a 75,000-litre vessel reaches 300 mg of paclitaxel per litre at harvest. Batch output = concentration × volume = 300 mg/L × 75,000 L = 22,500,000 mg = 22.5 kg per batch. The formula is the manager's whole strategy in one line: with the vessel fixed, output rises only if the concentration rises — which is why unglamorous yield work (line, elicitor timing, feeding, medium) outearns any plan that starts with buying bigger steel.
What actually reached the market — and two famous near-misses
The honour roll is short and instructive. Shikonin (Mitsui, 1984) proved cell culture could sell a product at all. Paclitaxel (Phyton's fermentation, licensed to Bristol-Myers Squibb in 1995) proved it could carry a major drug's supply. Ginseng cell biomass proved it could run big and steady: Panax ginseng cell cultures were grown in Japan in stirred tanks reported at around 20,000 litres, the biomass sold into foods and cosmetics for its ginsenosides. Berberine from selected Coptis lines reached production in Japan on the strength of the selection work described earlier. Each success shares the same profile: a high-value product, a plant supply that hurt, and a process tuned for years.
The near-misses teach as much. Catharanthus roseus (Madagascar periwinkle) cell cultures make the monomeric alkaloids catharanthine and vindoline, and ajmalicine and serpentine in quantity — but the dimeric anticancer drugs vinblastine and vincristine, the molecules everyone wanted, form in useful amounts only in the organised leaf. Decades of skilled work could not close that last gap in loose cells; the pathway map was complete, and the process still failed. Artemisinin, the antimalarial from Artemisia annua, stayed low in cultures and hairy roots alike; supply was secured by improved field plants and by engineered yeast making a precursor (artemisinic acid) for chemical finishing. The lesson is not that culture failed these molecules — it is that culture is one production tool among several, and it is chosen only when it wins.
Why most systems fail commercially: the honest limits
Hundreds of published systems produce a valuable compound in a flask. A handful produce it profitably in a tank. The gap is arithmetic, not effort: batch revenue is yield per litre × volume × price, and against it stand the costs of sterile steel run for weeks at a time, media, labour, and the downstream purification (separating one molecule from a soup of its cousins). Plant cells attack the revenue side from both ends — titres are usually low because the pathways idle in undifferentiated cells, and volumes fill slowly because the cells divide in days, not hours. A process crosses the line only when a high price meets a bad field supply: shikonin, paclitaxel and ginseng biomass fit; most others do not, yet.
The improvement levers of this lesson are all aimed at that arithmetic, and they compound: a selected line raises the ceiling, two-stage design lets the culture reach it, elicitors and feeding push in the same direction, trapping defends the gains, cell banking defends them across years, and the right reactor lets the whole design run at volume. What no lever can do is repeal the comparison with the field. Where a plant is common, fast and rich in the compound, the honest answer remains a farm — the judgement call is part of the science, and this course's haploid production lesson makes the same point in reverse: a laboratory method earns its place only where it beats the ordinary route.
Common mistakes in metabolite production work
Expecting the culture to match the plant automatically. Undifferentiated cells usually make little or nothing until a line is selected, elicited or organised. Budget the persuasion work from the start.
One medium for everything. Growth and production want different conditions. A single compromise medium usually delivers mediocre growth and mediocre product; stage the process.
Eliciting a young, thin culture. An elicitor thrown at a sparse culture gives a small response from few cells and may damage them. Grow first, switch conditions, then elicit.
Stirring plant cells like bacteria. The impeller settings that suit microbes tear large vacuolated cells. When cells are found ruptured, treat the mechanics, not the medium.
Trusting an old working line forever. Lines drift and yields slide silently. Keep a preserved master stock and restart campaigns from it.
Scaling the vessel before the biology. Output is concentration × volume. Doubling the tank doubles a weak process's costs along with its output; raise the titre first.
Questions and answers
Q. Can cultured cells ever out-produce the plant itself?
Yes, measured per gram of tissue. Selected Coptis lines held berberine at several percent of dry weight, and Coleus suspensions reached rosmarinic acid levels rivalling the leaf — because selection concentrates the best cells and the production stage removes every competing demand on them. The plant still wins on cost per hectare for most compounds, which is a different contest.
Q. Is a hairy root culture a genetically modified organism?
It carries bacterial T-DNA in its genome, transferred by the same natural mechanism that creates hairy roots in soil, so most regulatory systems treat hairy root lines as transgenic material for contained use. The products are ordinary plant compounds, chemically identical to those in the field root.
Q. Why not simply engineer yeast or bacteria to make every plant compound?
Sometimes that wins — the artemisinin precursor story in this lesson is exactly that. But long plant pathways with many enzymes, membrane steps and toxic intermediates can take a decade to rebuild in a microbe, and some have resisted rebuilding entirely. The plant's own cells start with the pathway already installed; that head start is the whole case for this lesson's methods.
Q. Which bioreactor should a first pilot project choose?
For a shear-sensitive suspension, an airlift or a wave reactor forgives beginner errors that a stirred tank punishes; for a process aimed at the largest volumes, the stirred tank's control eventually wins, with its impeller run gently. Choose for the cells' fragility first and the catalogue second.
Secondary metabolite production MCQs
Twenty multiple-choice questions with answers and explanations. Choose the best answer for each.
1. What is a plant secondary metabolite?
A. A hormone that controls the timing of flowering in all plants
B. A sugar or amino acid that every living cell needs for its everyday growth
C. A waste product that the plant produces by accident and cannot get rid of
D. A compound the plant makes for defence, attraction or signalling rather than for basic growth and division — a pigment, a toxin, a scent or a bitter alkaloid
Answer: D. A compound the plant makes for defence, attraction or signalling rather than for basic growth and division — a pigment, a toxin, a scent or a bitter alkaloid
Secondary metabolites are not part of the cell's basic growth machinery (that is the primary metabolites: sugars, amino acids, nucleotides). They are working chemicals of the plant's life in the world — poisons that deter grazers, pigments that attract pollinators, signals to microbes — and each kind is usually made by only a few plant groups.
2. Why would a company grow plant cells in a steel tank instead of simply harvesting the plant?
A. Governments have banned the harvesting of all medicinal plants
B. The source plant may be slow-growing, rare or low in the compound, while the molecule is too complex to make cheaply by chemistry — culture offers a controlled, year-round supply
C. Cultured cells always grow faster than bacteria, so they are cheaper for every product
D. Plant cells in a tank need no nutrients, light or sterile conditions
Answer: B. The source plant may be slow-growing, rare or low in the compound, while the molecule is too complex to make cheaply by chemistry — culture offers a controlled, year-round supply
Cell culture earns its place when field supply fails: a yew tree needs decades to grow and holds little paclitaxel in its bark, and the molecule's structure defeats cheap synthesis. A tank of Taxus cells grows all year, anywhere, under control. Where the plant is common and rich in the compound, the field usually wins on cost — which is why the commercial list of culture products is short.
3. What is a cell suspension culture?
A. A row of whole plants floating in a pond of nutrient solution
B. Callus broken up and grown as small clumps and single cells dispersed in liquid medium, kept moving by shaking or stirring
C. A culture of bacteria that feeds on dead plant cells
D. Cells frozen in liquid nitrogen until they are needed
Answer: B. Callus broken up and grown as small clumps and single cells dispersed in liquid medium, kept moving by shaking or stirring
A suspension starts from friable (soft, crumbly) callus placed in liquid medium. Movement keeps the cells dispersed as small aggregates bathed in nutrients — the only culture form that fits naturally into large stirred or air-driven vessels, and so the standard starting point for metabolite production.
4. A new cell line from a medicinal plant grows well but makes almost none of the plant's famous drug. What is the most likely reason?
A. The medium contains too much sucrose, which destroys all secondary metabolites
B. The cells have forgotten how to photosynthesise, and all metabolite pathways need light
C. Secondary metabolites can only be made by cells taken from the roots of old trees
D. In the whole plant the pathway runs in specialised cells or structures that undifferentiated callus cells lack, so the line must be selected, elicited or partly organised before it produces
Answer: D. In the whole plant the pathway runs in specialised cells or structures that undifferentiated callus cells lack, so the line must be selected, elicited or partly organised before it produces
Many pathways are developmentally switched on: the enzymes and storage sites exist in a leaf gland, a bark layer or a root, not in a lump of callus. The standard escapes are screening many lines for a rare high producer, adding elicitors that switch defence pathways on, feeding precursors, or using an organised culture such as hairy roots that keeps the pathway's home tissue alive.
5. Which product was the first to be sold commercially from plant cell culture, and who produced it?
A. Insulin, produced from tobacco cells in 1962
B. Paclitaxel, produced by Phyton in Germany in 1975
C. Shikonin, a red pigment from Lithospermum erythrorhizon cell cultures, brought to market by Mitsui in Japan in 1984
D. Vanillin, produced from vanilla orchid cells in 1950
Answer: C. Shikonin, a red pigment from Lithospermum erythrorhizon cell cultures, brought to market by Mitsui in Japan in 1984
Shikonin was the proof that the idea could pay. Mitsui Petrochemical Industries scaled up Lithospermum erythrorhizon cell cultures and sold the red naphthoquinone pigment (for cosmetics such as lipstick) in 1984 — the first commercial product of plant cell culture, a full decade before paclitaxel production followed.
6. In the classic shikonin process, why was the culture run in two stages?
A. Two stages are needed because the pigment is harvested from the dead cells of stage one
B. The first stage sterilises the cells and the second stage washes them
C. The medium that grows cells fastest is not the medium that makes them produce: a growth medium first builds biomass, then a special production medium (M-9) switches the cells to making pigment
D. Cells must be grown once in the dark and once in the light to make any pigment
Answer: C. The medium that grows cells fastest is not the medium that makes them produce: a growth medium first builds biomass, then a special production medium (M-9) switches the cells to making pigment
Fujita's team found that shikonin formation needed its own conditions: cells multiplied in a growth medium, then moved to the M-9 production medium, where they accumulated shikonin derivatives to around 10% of their dry weight. The two-stage design — grow first, produce second — became the template for metabolite production generally, because growth and production usually want different media.
7. What is an elicitor, in metabolite production work?
A. A dye for staining living cells so they can be counted
B. A substance that mimics attack or stress and switches on the plant's defence pathways, which often raises production of defensive secondary metabolites
C. A machine that pumps air through a bioreactor
D. An enzyme that breaks the product down into simpler compounds
Answer: B. A substance that mimics attack or stress and switches on the plant's defence pathways, which often raises production of defensive secondary metabolites
Most valuable metabolites are defence chemicals, so pretending the culture is under attack is a powerful switch. Fungal preparations, chitosan, yeast extract, the signal molecule methyl jasmonate, and abiotic stresses such as UV or metal salts all act as elicitors: the cells answer by running the pathways that make the product.
8. Which treatment is a standard way to raise paclitaxel production in Taxus cell cultures?
A. Adding extra auxin so the cells divide as fast as possible
B. Keeping the culture in complete darkness for the whole run
C. Adding penicillin to stop the cells making any other compounds
D. Adding methyl jasmonate, a plant defence signal, as an elicitor once the culture has grown
Answer: D. Adding methyl jasmonate, a plant defence signal, as an elicitor once the culture has grown
Paclitaxel is part of the yew's chemical defence, so the jasmonate signal — the plant's own wound alarm — turns its pathway up. Methyl jasmonate elicitation, applied after the growth phase, is a standard step in Taxus culture work and is one of the best-documented elicitor effects in the field.
9. A team screens 400 candidate cell lines for a new production project. On past experience, 5% of lines turn out to be high producers worth keeping. How many lines should they expect to keep?
A. 80 lines
B. 40 lines
C. 20 lines
D. 5 lines
Answer: C. 20 lines
Expected high producers = population x frequency: 400 x 5/100 = 20. Screening arithmetic sets the scale of every cell-line project — hundreds of lines must be grown and assayed so that a few dozen candidates survive, exactly as in the somaclone screens of the previous lesson.
10. What is precursor feeding?
A. Feeding the culture with ground-up whole plants of the same species
B. Supplying the culture with a building block from part-way along the product's pathway, so the cells can finish making the product instead of building the block themselves
C. Adding the finished product to the medium so the cells absorb it
D. Giving the cells extra sucrose so they grow faster
Answer: B. Supplying the culture with a building block from part-way along the product's pathway, so the cells can finish making the product instead of building the block themselves
If an early step of a pathway is the bottleneck, feeding a later intermediate can lift production — phenylalanine, for example, feeds phenolic products such as rosmarinic acid. The cell still does the skilled final chemistry; the feeder simply removes a traffic jam upstream.
11. Why is a second, product-trapping phase (a resin or an oil layer) sometimes added to a production culture?
A. The resin sterilises the medium so no autoclave is needed
B. Secreted product is captured as fast as it leaves the cells, which relieves feedback inhibition and stops the product breaking down or harming the cells
C. The second phase makes the cells divide twice as fast
D. The oil layer feeds the cells with extra carbon
Answer: B. Secreted product is captured as fast as it leaves the cells, which relieves feedback inhibition and stops the product breaking down or harming the cells
Many metabolites are stored outside the producing cell or leak into the medium, where they can switch their own pathway off (feedback inhibition) or degrade. A resin such as XAD, or an inert oil layer, traps the product in situ: the cells keep producing, and harvest becomes a matter of collecting the trap instead of the whole broth. The classic shikonin work used a paraffin layer for exactly this.
12. What does it mean to immobilise cultured plant cells?
A. The cells are killed and dried so they can be stored
B. The cells are frozen solid inside the bioreactor
C. The cells are trapped inside a gel bead or foam matrix: they stay in place while medium flows past them, so medium can be exchanged and secreted product collected without harvesting the cells
D. The cells are glued to the walls of the culture flask so they cannot be sampled
Answer: C. The cells are trapped inside a gel bead or foam matrix: they stay in place while medium flows past them, so medium can be exchanged and secreted product collected without harvesting the cells
Calcium alginate beads and polyurethane foam are the classic matrices. Immobilised cells grow slowly but stay alive and productive for long periods, the medium can be changed without losing the biomass, and product released into the medium is easy to collect — shikonin cells immobilised in polyurethane foam are the textbook case.
13. Hairy root cultures are started by infecting plant tissue with which bacterium, and what does the bacterium hand over?
A. Escherichia coli: it hands over a plasmid carrying an insulin gene
B. Bacillus subtilis: it hands over spores that grow into roots
C. Agrobacterium tumefaciens: it hands over a Ti plasmid that makes the tissue form a tumour
D. Agrobacterium rhizogenes (now Rhizobium rhizogenes): its Ri plasmid transfers T-DNA carrying rol genes into the plant genome, and roots pour out at the infection site
Answer: D. Agrobacterium rhizogenes (now Rhizobium rhizogenes): its Ri plasmid transfers T-DNA carrying rol genes into the plant genome, and roots pour out at the infection site
A. rhizogenes is a natural genetic engineer of roots. The rol genes on the transferred T-DNA reprogramme the infected cells into fast-growing, highly branched roots that need no added hormones. Because the change is written into the plant genome of every root cell, the culture is stable — the foundation of the hairy-root production system.
14. Why are hairy roots often better than callus at making root-type products such as tropane alkaloids or ginsenosides?
A. They grow in the dark, and darkness is required for all alkaloid synthesis
B. Hairy roots make every product at exactly the level found in field plants
C. They are organised root tissue, so the pathways that belong in roots stay switched on, and the culture is genetically stable and grows fast without hormones
D. Roots contain no DNA, so nothing can go wrong with the pathway
Answer: C. They are organised root tissue, so the pathways that belong in roots stay switched on, and the culture is genetically stable and grows fast without hormones
Organisation is the point. A hairy root is still a root: its cells keep their root identity, so root pathways — tropane alkaloids in Hyoscyamus and Atropa, ginsenosides in Panax — keep running at useful levels, without the drift and decline that plague long-kept callus lines.
15. Why is an airlift bioreactor often chosen over a stirred tank for plant cell suspensions?
A. An airlift vessel can be run without any sterile precautions
B. Rising air bubbles circulate the broth through a draught tube, so mixing happens with no impeller blades tearing at the large, fragile cells
C. Plant cells produce their own oxygen, so no air supply is needed at all
D. The draught tube grinds the cell aggregates into single cells
Answer: B. Rising air bubbles circulate the broth through a draught tube, so mixing happens with no impeller blades tearing at the large, fragile cells
The stirred tank mixes best but its impeller is the main source of shear. In an airlift reactor the only moving part is the air: bubbles rise in the draught tube, broth circulates gently in a loop, and oxygen arrives with the mixing. For shear-sensitive plant cells that trade is usually worth the slightly weaker mixing.
16. Why are plant cells so easily damaged by vigorous stirring — the shear problem?
A. Plant cells are damaged only by metal, and impellers are always made of metal
B. Plant cells have no cell walls, so they burst at the slightest touch
C. Stirring removes the carbon dioxide that plant cells need to survive
D. They are large (tens of micrometres), carry a big central vacuole and grow in aggregates, so mechanical stress that microbes shrug off can rupture them
Answer: D. They are large (tens of micrometres), carry a big central vacuole and grow in aggregates, so mechanical stress that microbes shrug off can rupture them
A bacterial cell is a micrometre-scale pressure vessel; a plant cell is a large, water-filled balloon of tens of micrometres, often stuck to its neighbours in aggregates. Turbulent eddies and impeller tips that microbes ignore can tear plant cells apart — shear stress is the central design problem of plant-cell bioreactors.
17. What is special about Phyton's paclitaxel production, as a matter of scale?
A. Taxus cells are grown by plant cell fermentation in stirred vessels of up to 75,000 litres — among the largest plant-cell processes ever run, with over 200,000 litres installed
B. The whole world supply is made in a single 10-litre flask
C. The process uses genetically modified bacteria in 75,000-litre tanks
D. Paclitaxel is made by growing yew trees inside a greenhouse bioreactor
Answer: A. Taxus cells are grown by plant cell fermentation in stirred vessels of up to 75,000 litres — among the largest plant-cell processes ever run, with over 200,000 litres installed
Phyton Biotech's German plant runs plant cell fermentation with production vessels of 45,000 and 75,000 litres — proof that plant cells, for all their slowness and shear sensitivity, can be run at true industrial scale when the product is valuable enough. Bristol-Myers Squibb licensed the process in 1995 to escape dependence on yew bark.
18. Why did artemisinin not become a plant-cell-culture product, despite much work on Artemisia annua cultures?
A. Artemisinin cannot be detected by any known chemical test
B. Culture yields stayed low, and supply was secured instead by field-grown plants plus engineered yeast making a precursor for chemical finishing — culture was not the winning route
C. Artemisia cells refuse to grow in any liquid medium
D. The drug was banned because it is also made by a fungus
Answer: B. Culture yields stayed low, and supply was secured instead by field-grown plants plus engineered yeast making a precursor for chemical finishing — culture was not the winning route
Artemisia cultures and hairy roots made only modest amounts of artemisinin, and the economics never closed. Breeders improved the field plant while engineers put the pathway's first half into yeast (making artemisinic acid for chemical conversion) — the standing lesson that culture is one production tool among several, chosen only when it wins.
19. A berberine project reports that its best Coptis japonica cell lines hold several percent of their dry weight as berberine. What made such lines possible?
A. All Coptis cells naturally hold the same high level, so no work was needed
B. The cells were grown in total darkness for ten years
C. Berberine was added to the medium and simply soaked into the cells
D. Repeated screening and selection: from a variable population of cultured cells, the rare high-producing cells were picked out and grown on, cycle after cycle
Answer: D. Repeated screening and selection: from a variable population of cultured cells, the rare high-producing cells were picked out and grown on, cycle after cycle
Cultured cell populations are heterogeneous (the somaclonal variation of the last lesson, working for the producer). Sato and Yamada's Coptis work is the model: assay many small cultures, keep the top producers, repeat. Best lines reached several percent of dry weight as berberine — reported up to roughly 13% — far above the root level.
20. A production culture that once yielded well slowly loses yield over many subcultures. What is the soundest first response?
A. Accept the loss; nothing can be done once a line declines
B. Mix the old culture with a different species to refresh it
C. Return to a preserved master stock of the original high-producing line (a cell bank) and restart from it, rather than trusting the drifted working culture
D. Add more auxin to force the old culture to produce again
Answer: C. Return to a preserved master stock of the original high-producing line (a cell bank) and restart from it, rather than trusting the drifted working culture
Long-kept lines drift — somaclonal change accumulates and fast-growing low producers outgrow the rest. Industrial practice answers with banking: a master stock of the verified high-producing line is preserved (commonly cryopreserved), and production runs are restarted from it before drift eats the yield.
Secondary metabolite production quiz
Twenty questions. Answer all twenty, then press Submit to see your score.
Question 1 of 20. Paclitaxel (Taxol) is obtained from cell cultures of which plant?
Question 2 of 20. A paclitaxel vessel of 75,000 litres reaches a product concentration of 300 mg per litre at harvest. How much paclitaxel does one batch contain?
Question 3 of 20. Rosmarinic acid became a model product of cell culture work in which species?
Question 4 of 20. What are ginsenosides, and from what are they produced in culture?
Question 5 of 20. One claim about metabolite production in culture is wrong. Which one?
Question 6 of 20. Chitosan, prepared from chitin, is used in production cultures as what?
Question 7 of 20. In many production systems the product accumulates mainly after growth slows down. Why?
Question 8 of 20. What is the main weakness of a simple bubble column bioreactor at large scale?
Question 9 of 20. What is a wave bioreactor, and why does it suit plant cells?
Question 10 of 20. Why are hairy root cultures difficult to scale up, despite their excellent production?
Question 11 of 20. What is a seed train, in scale-up work?
Question 12 of 20. A stirred-tank run with plant cells fails: growth is poor and many cells are found ruptured. Which single change most directly addresses the cause?
Question 13 of 20. Which culture system is generally the most genetically stable over long production runs?
Question 14 of 20. Catharanthus roseus cell cultures taught the field a famous lesson. What was it?
Question 15 of 20. What most often decides whether a culture process reaches the market?
Question 16 of 20. Limiting a nutrient such as phosphate or nitrate in the production stage often raises metabolite output. Why?
Question 17 of 20. Shikonin itself belongs to which class of compound, and what does it look like?
Question 18 of 20. In a two-stage production process, which stage comes first and what is it for?
Question 19 of 20. Cells immobilised in calcium alginate are held in what physical form?
Question 20 of 20. A factory wants more product from the same Taxus cell line without buying a bigger vessel. Which plan is soundest?
Continue learning
- Plant Tissue Culture course (BOT-608) — full lesson list
- Plant Tissue Culture Laboratory: Organisation, Equipment and Safety
- Haploid Production in Plants: Anther Culture, Pollen Culture and Doubled Haploids
- Somaclonal Variation in Plants: Causes, Detection and Uses in Crop Improvement
- Cell Suspension Culture in Plant Tissue Culture
- Root and Hairy Root Cultures in Plant Tissue Culture
Sources
- Fujita Y, Hara Y, Suga C, Morimoto T (1981). Production of shikonin derivatives by cell suspension cultures of Lithospermum erythrorhizon. II. A new medium for the production of shikonin derivatives. Plant Cell Reports 1: 61–63.
- Yazaki K (2017). Lithospermum erythrorhizon cell cultures: present and future aspects. Plant Biotechnology 34: 131–142.
- Zhong JJ (2002). Plant cell culture for production of paclitaxel and other taxanes. Journal of Bioscience and Bioengineering 94: 591–599.
- Wilson SA, Roberts SC (2012). Recent advances towards development and commercialization of plant cell culture processes for the synthesis of biomolecules. Plant Biotechnology Journal 10: 249–268.
- Georgiev MI, Weber J, Maciuk A (2009). Bioprocessing of plant cell cultures for mass production of targeted compounds. Applied Microbiology and Biotechnology 83: 809–823.
- Verpoorte R, Contin A, Memelink J (2002). Biotechnology for the production of plant secondary metabolites. Phytochemistry Reviews 1: 13–25.
- Zhao J, Davis LC, Verpoorte R (2005). Elicitor signal transduction leading to production of plant secondary metabolites. Biotechnology Advances 23: 283–333.
- Guillon S, Trémouillaux-Guiller J, Pati PK, Rideau M, Gantet P (2006). Harnessing the potential of hairy roots: dawn of a new era. Trends in Biotechnology 24: 403–409.
- Georgiev MI, Pavlov AI, Bley T (2007). Hairy root type plant in vitro systems as sources of bioactive substances. Applied Microbiology and Biotechnology 74: 1175–1185.
- Murthy HN, Lee EJ, Paek KY (2014). Production of secondary metabolites from cell and organ cultures: strategies and approaches for biomass improvement and metabolite accumulation. Plant Cell, Tissue and Organ Culture 118: 1–16.
- Georgiev MI, Weber J (2014). Bioreactors for plant cells: hardware configuration and internal environment optimization as tools for wider commercialization. Biotechnology Letters 36: 1359–1367.
- Phyton Biotech (company materials, read 2026). Plant cell fermentation of paclitaxel: production vessels of 45,000 and 75,000 litres, over 200,000 litres installed capacity.
- AQA A-level Biology 7402 specification (genetic technology and gene expression sections); OCR A-level Biology A H432 specification (plant biotechnology); College Board AP Biology framework, Unit 6 (gene expression and regulation).
0 Comments
Have a biology question or spotted an error?
Send feedback to PreachBio →